Sanofi
SNYNFOTCHealthcare● Active
$88.31
+$0.60(+0.68%)
Market Cap$106.2B
P/E Ratio—
52W High$106.34
52W Low$83.17
Sanofi（SNYNF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SNYNF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $43.61B | $44.29B | $41.62B | $40.30B | $39.17B |
| Cost of Revenue | $13.04B | $13.21B | $12.63B | $11.88B | $12.26B |
| Gross Profit | $30.57B | $31.08B | $23.19B | $26.99B | $26.92B |
| Gross Margin %(computed) | 70.09% | 70.18% | 55.72% | 66.98% | 68.72% |
| Operating Expenses | |||||
| R&D Expenses | $7.84B | $7.39B | $6.73B | $6.50B | $5.69B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $16.32B | $23.83B | $15.38B | $18.52B | $18.79B |
| Operating Income | $14.25B | $14.45B | $12.98B | $13.15B | $8.13B |
| Operating Margin %(computed) | 32.67% | 32.63% | 31.19% | 32.62% | 20.74% |
| Interest Income | $0.39B | $0.41B | $0.53B | $0.17B | $0.00B |
| Interest Expense | $0.56B | $0.75B | $0.71B | $0.39B | $0.39B |
| Income Before Tax | $6.02B | $6.76B | $6.12B | $9.99B | $7.84B |
| Income Tax Expense | $1.04B | $1.20B | $1.02B | $1.91B | $1.56B |
| Net Income | $7.81B | $5.56B | $5.40B | $8.37B | $6.22B |
| Net Margin %(computed) | 17.91% | 12.55% | 12.98% | 20.77% | 15.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.40 | $4.45 | $4.30 | $6.69 | $4.97 |
| Wtd Avg Shares | 1.22B | 1.25B | 1.26B | 1.25B | 1.25B |
| EBITDA | $6.74B | $10.92B | $11.08B | $13.51B | $11.25B |
| EBITDA Margin %(computed) | 15.44% | 24.66% | 26.61% | 33.52% | 28.72% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · EUR · B
深入了解Sanofi
关于Sanofi（SNYNF）损益表
Sanofi（SNYNF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SNYNF实现营收$43.61B，毛利润$30.57B（毛利率70.09%），净利润$7.81B（净利率17.91%）。
常见问题
SNYNF · 4 问Sanofi（SNYNF）2025财年营收为$43.61B，同比down1.5%。
SNYNF revenueSNYNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08